Insider Trades161 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 900 | $40.95 | $5.3B | -0.27% | +154.84% | $36.9K | -1.03% | — | Stalk |
| Apr 17, 2026 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 22,192 | $40.90 | $5.3B | -0.27% | +154.84% | $907.7K | +0.00% | — | Stalk |
| Mar 11, 2026 | Sell | APLS | Cedric Francois | Chief Executive Officer | 129,738 | $19.38 | $5.3B | -0.27% | +154.84% | $2.5M | +0.00% | — | Stalk |
| Feb 11, 2026 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 368 | $22.15 | $5.3B | -0.27% | +154.84% | $8.2K | -0.32% | — | Stalk |
| Feb 3, 2026 | Buy | APLS | Cedric Francois | Chief Executive Officer | 8,840 | $3.76 | $5.3B | -0.27% | +154.84% | $33.2K | +1.83% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 2,064 | $21.77 | $5.3B | -0.27% | +154.84% | $44.9K | -3.98% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 2,797 | $21.77 | $5.3B | -0.27% | +154.84% | $60.9K | -3.13% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 3,371 | $21.77 | $5.3B | -0.27% | +154.84% | $73.4K | -4.12% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 5,928 | $21.77 | $5.3B | -0.27% | +154.84% | $129.0K | -0.51% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 7,725 | $21.77 | $5.3B | -0.27% | +154.84% | $168.1K | -9.80% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | David O. Watson | General Counsel | 7,832 | $21.77 | $5.3B | -0.27% | +154.84% | $170.5K | -8.13% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 10,287 | $21.77 | $5.3B | -0.27% | +154.84% | $223.9K | -9.87% | — | Stalk |
| Jan 22, 2026 | Sell | APLS | Cedric Francois | Chief Executive Officer | 27,192 | $21.77 | $5.3B | -0.27% | +154.84% | $591.8K | -8.68% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 726 | $19.79 | $5.3B | -0.27% | +154.84% | $14.4K | -1.38% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 909 | $19.79 | $5.3B | -0.27% | +154.84% | $18.0K | -0.08% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,334 | $19.79 | $5.3B | -0.27% | +154.84% | $26.4K | -1.61% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 1,882 | $19.79 | $5.3B | -0.27% | +154.84% | $37.3K | -2.06% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 2,203 | $19.79 | $5.3B | -0.27% | +154.84% | $43.6K | -2.72% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | David O. Watson | General Counsel | 2,475 | $19.79 | $5.3B | -0.27% | +154.84% | $49.0K | -2.50% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 2,892 | $19.79 | $5.3B | -0.27% | +154.84% | $57.2K | -2.70% | — | Stalk |
| Jan 20, 2026 | Sell | APLS | Cedric Francois | Chief Executive Officer | 8,182 | $19.79 | $5.3B | -0.27% | +154.84% | $161.9K | -2.55% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 873 | $22.19 | $5.3B | -0.27% | +154.84% | $19.4K | -1.63% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,780 | $22.19 | $5.3B | -0.27% | +154.84% | $39.5K | -2.10% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 2,277 | $22.19 | $5.3B | -0.27% | +154.84% | $50.5K | -0.20% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 2,618 | $22.19 | $5.3B | -0.27% | +154.84% | $58.1K | -3.13% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 3,856 | $22.19 | $5.3B | -0.27% | +154.84% | $85.6K | -3.48% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | David O. Watson | General Counsel | 5,780 | $22.19 | $5.3B | -0.27% | +154.84% | $128.2K | -5.52% | — | Stalk |
| Jan 13, 2026 | Sell | APLS | Cedric Francois | Chief Executive Officer | 10,186 | $22.19 | $5.3B | -0.27% | +154.84% | $226.0K | -3.07% | — | Stalk |
| Jan 7, 2026 | Buy | APLS | David O. Watson | General Counsel | 888 | $14.95 | $5.3B | -0.27% | +154.84% | $13.3K | +0.75% | — | Stalk |
| Jan 5, 2026 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 3,020 | $25.53 | $5.3B | -0.27% | +154.84% | $77.1K | -3.21% | — | Stalk |
| Dec 16, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $24.49 | $5.3B | -0.27% | +154.84% | $122.4K | -4.60% | 10b5-1 | Stalk |
| Nov 17, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $20.06 | $5.3B | -0.27% | +154.84% | $100.3K | -4.40% | 10b5-1 | Stalk |
| Oct 21, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 20,000 | $19.03 | $5.3B | -0.27% | +154.84% | $380.6K | +0.00% | 10b5-1 | Stalk |
| Oct 16, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $25.22 | $5.3B | -0.27% | +154.84% | $126.1K | -4.21% | 10b5-1 | Stalk |
| Sep 16, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $24.34 | $5.3B | -0.27% | +154.84% | $121.7K | -4.04% | 10b5-1 | Stalk |
| Sep 15, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 189 | $24.19 | $5.3B | -0.27% | +154.84% | $4.6K | -0.35% | — | Stalk |
| Sep 10, 2025 | Sell | APLS | David O. Watson | General Counsel | 20,000 | $26.17 | $5.3B | -0.27% | +154.84% | $523.4K | -28.52% | — | Stalk |
| Sep 8, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 57,729 | $23.22 | $5.3B | -0.27% | +154.84% | $1.3M | -4.73% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 548 | $28.08 | $5.3B | -0.27% | +154.84% | $15.4K | -1.01% | — | Stalk |
| Aug 27, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 225,000 | $28.23 | $5.3B | -0.27% | +154.84% | $6.4M | -25.26% | — | Stalk |
| Aug 18, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $27.80 | $5.3B | -0.27% | +154.84% | $139.0K | -3.88% | 10b5-1 | Stalk |
| Jul 17, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 28,722 | $15.23 | $5.3B | -0.27% | +154.84% | $437.5K | -1.35% | 10b5-1 | Stalk |
| Jul 16, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $19.55 | $5.3B | -0.27% | +154.84% | $97.8K | -3.74% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 205,368 | $15.08 | $5.3B | -0.27% | +154.84% | $3.1M | -4.07% | 10b5-1 | Stalk |
| Jun 16, 2025 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $18.77 | $5.3B | -0.27% | +154.84% | $93.8K | -3.60% | 10b5-1 | Stalk |
| May 21, 2025 | Buy | APLS | Pascal Deschatelets | Chief Scientific Officer | 12,780 | $3.76 | $5.3B | -0.27% | +154.84% | $48.1K | +1.11% | — | Stalk |
| Mar 17, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 183 | $24.82 | $5.3B | -0.27% | +154.84% | $4.5K | -0.38% | — | Stalk |
| Mar 4, 2025 | Sell | APLS | David O. Watson | General Counsel | 18,903 | $7.40 | $5.3B | -0.27% | +154.84% | $139.8K | -3.61% | — | Stalk |
| Feb 11, 2025 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 363 | $28.54 | $5.3B | -0.27% | +154.84% | $10.4K | -0.43% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 278 | $29.52 | $5.3B | -0.27% | +154.84% | $8.2K | -0.50% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Karen Lewis | Chief People Officer | 364 | $29.52 | $5.3B | -0.27% | +154.84% | $10.7K | -0.52% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 365 | $29.52 | $5.3B | -0.27% | +154.84% | $10.8K | -0.43% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 546 | $29.52 | $5.3B | -0.27% | +154.84% | $16.1K | -0.42% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 695 | $29.52 | $5.3B | -0.27% | +154.84% | $20.5K | -0.82% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | David O. Watson | General Counsel | 695 | $29.52 | $5.3B | -0.27% | +154.84% | $20.5K | -0.48% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 825 | $29.52 | $5.3B | -0.27% | +154.84% | $24.4K | -0.98% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 826 | $29.52 | $5.3B | -0.27% | +154.84% | $24.4K | -0.07% | — | Stalk |
| Jan 29, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 2,824 | $29.52 | $5.3B | -0.27% | +154.84% | $83.4K | -0.67% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 1,096 | $30.43 | $5.3B | -0.27% | +154.84% | $33.3K | -2.23% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 1,291 | $30.43 | $5.3B | -0.27% | +154.84% | $39.3K | -2.27% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,396 | $30.43 | $5.3B | -0.27% | +154.84% | $42.5K | -1.62% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Karen Lewis | Chief People Officer | 1,751 | $30.43 | $5.3B | -0.27% | +154.84% | $53.3K | -2.42% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 3,088 | $30.43 | $5.3B | -0.27% | +154.84% | $94.0K | -2.33% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 3,323 | $30.43 | $5.3B | -0.27% | +154.84% | $101.1K | -3.77% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | David O. Watson | General Counsel | 3,323 | $30.43 | $5.3B | -0.27% | +154.84% | $101.1K | -2.24% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 3,948 | $30.43 | $5.3B | -0.27% | +154.84% | $120.1K | -0.34% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 3,948 | $30.43 | $5.3B | -0.27% | +154.84% | $120.1K | -4.46% | — | Stalk |
| Jan 22, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 13,551 | $30.43 | $5.3B | -0.27% | +154.84% | $412.3K | -3.14% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 715 | $29.96 | $5.3B | -0.27% | +154.84% | $21.4K | -1.91% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 750 | $29.96 | $5.3B | -0.27% | +154.84% | $22.5K | -0.07% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,235 | $29.96 | $5.3B | -0.27% | +154.84% | $37.0K | -2.10% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Karen Lewis | Chief People Officer | 1,241 | $29.96 | $5.3B | -0.27% | +154.84% | $37.2K | -2.75% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 1,730 | $29.96 | $5.3B | -0.27% | +154.84% | $51.8K | -1.96% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 1,853 | $29.96 | $5.3B | -0.27% | +154.84% | $55.5K | -3.34% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 2,145 | $29.96 | $5.3B | -0.27% | +154.84% | $64.3K | -3.96% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 2,201 | $29.96 | $5.3B | -0.27% | +154.84% | $65.9K | -2.44% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | David O. Watson | General Counsel | 2,201 | $29.96 | $5.3B | -0.27% | +154.84% | $65.9K | -2.04% | — | Stalk |
| Jan 17, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 6,007 | $29.96 | $5.3B | -0.27% | +154.84% | $180.0K | -1.95% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 264 | $28.70 | $5.3B | -0.27% | +154.84% | $7.6K | -0.46% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 783 | $28.70 | $5.3B | -0.27% | +154.84% | $22.5K | -2.05% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,599 | $28.70 | $5.3B | -0.27% | +154.84% | $45.9K | -2.65% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Karen Lewis | Chief People Officer | 1,599 | $28.70 | $5.3B | -0.27% | +154.84% | $45.9K | -3.42% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 2,170 | $28.70 | $5.3B | -0.27% | +154.84% | $62.3K | -2.40% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 2,288 | $28.70 | $5.3B | -0.27% | +154.84% | $65.7K | -0.20% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 2,632 | $28.70 | $5.3B | -0.27% | +154.84% | $75.5K | -4.63% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 2,685 | $28.70 | $5.3B | -0.27% | +154.84% | $77.1K | -2.89% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | David O. Watson | General Counsel | 4,965 | $28.70 | $5.3B | -0.27% | +154.84% | $142.5K | -4.40% | — | Stalk |
| Jan 13, 2025 | Sell | APLS | Cedric Francois | Chief Executive Officer | 6,247 | $28.70 | $5.3B | -0.27% | +154.84% | $179.3K | -1.99% | — | Stalk |
| Jan 6, 2025 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 2,816 | $33.81 | $5.3B | -0.27% | +154.84% | $95.2K | -4.82% | — | Stalk |
| Dec 31, 2024 | Buy | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 11,096 | $13.95 | $5.3B | -0.27% | +154.84% | $154.8K | +4.14% | — | Stalk |
| Dec 23, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 63 | $33.09 | $5.3B | -0.27% | +154.84% | $2.1K | -0.11% | — | Stalk |
| Dec 11, 2024 | Sell | APLS | David O. Watson | General Counsel | 5,000 | $34.23 | $5.3B | -0.27% | +154.84% | $171.2K | -4.25% | — | Stalk |
| Sep 27, 2024 | Sell | APLS | David O. Watson | General Counsel | 21,138 | $29.47 | $5.3B | -0.27% | +154.84% | $622.9K | +0.00% | — | Stalk |
| Sep 16, 2024 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 192 | $36.21 | $5.3B | -0.27% | +154.84% | $7.0K | -0.50% | — | Stalk |
| Sep 3, 2024 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 550 | $39.49 | $5.3B | -0.27% | +154.84% | $21.7K | -1.41% | — | Stalk |
| Aug 12, 2024 | Buy | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 5,201 | $13.85 | $5.3B | -0.27% | +154.84% | $72.0K | +7.43% | — | Stalk |
| May 20, 2024 | Buy | APLS | Pascal Deschatelets | Chief Scientific Officer | 24,500 | $3.76 | $5.3B | -0.27% | +154.84% | $92.1K | +2.17% | — | Stalk |
| May 8, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 157,814 | $23.33 | $5.3B | -0.27% | +154.84% | $3.7M | +0.00% | 10b5-1 | Stalk |
| Apr 18, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 28,328 | $47.51 | $5.3B | -0.27% | +154.84% | $1.3M | +0.00% | — | Stalk |
| Apr 8, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 138,214 | $28.97 | $5.3B | -0.27% | +154.84% | $4.0M | +0.00% | 10b5-1 | Stalk |
| Apr 1, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 8,000 | $34.34 | $5.3B | -0.27% | +154.84% | $274.8K | +0.00% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 9,913 | $56.90 | $5.3B | -0.27% | +154.84% | $564.0K | -15.34% | — | Stalk |
| Mar 15, 2024 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 184 | $56.46 | $5.3B | -0.27% | +154.84% | $10.4K | -0.47% | — | Stalk |
| Mar 13, 2024 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 11,220 | $57.56 | $5.3B | -0.27% | +154.84% | $645.8K | -8.82% | — | Stalk |
| Mar 8, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 138,214 | $32.93 | $5.3B | -0.27% | +154.84% | $4.6M | +0.00% | 10b5-1 | Stalk |
| Mar 6, 2024 | Buy | APLS | David O. Watson | General Counsel | 3,762 | $13.85 | $5.3B | -0.27% | +154.84% | $52.1K | +3.64% | — | Stalk |
| Mar 1, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 12,000 | $36.63 | $5.3B | -0.27% | +154.84% | $439.5K | +0.00% | 10b5-1 | Stalk |
| Mar 1, 2024 | Sell | APLS | Cedric Francois | Chief Executive Officer | 500,000 | $34.16 | $5.3B | -0.27% | +154.84% | $17.1M | +0.00% | 10b5-1 | Stalk |
| Feb 12, 2024 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 597 | $67.77 | $5.3B | -0.27% | +154.84% | $40.5K | -0.92% | — | Stalk |
| Feb 12, 2024 | Sell | APLS | David O. Watson | General Counsel | 781 | $67.77 | $5.3B | -0.27% | +154.84% | $52.9K | -0.75% | — | Stalk |
| Feb 12, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 1,148 | $67.77 | $5.3B | -0.27% | +154.84% | $77.8K | -0.10% | — | Stalk |
| Feb 12, 2024 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 1,148 | $67.77 | $5.3B | -0.27% | +154.84% | $77.8K | -1.23% | — | Stalk |
| Feb 12, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 1,431 | $67.77 | $5.3B | -0.27% | +154.84% | $97.0K | -1.51% | — | Stalk |
| Feb 12, 2024 | Sell | APLS | Cedric Francois | Chief Executive Officer | 3,962 | $67.77 | $5.3B | -0.27% | +154.84% | $268.5K | -1.25% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 367 | $64.14 | $5.3B | -0.27% | +154.84% | $23.5K | -0.56% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 835 | $64.14 | $5.3B | -0.27% | +154.84% | $53.6K | -1.22% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 874 | $64.14 | $5.3B | -0.27% | +154.84% | $56.1K | -0.08% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 906 | $64.14 | $5.3B | -0.27% | +154.84% | $58.1K | -0.95% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 906 | $64.14 | $5.3B | -0.27% | +154.84% | $58.1K | -0.96% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | David O. Watson | General Counsel | 906 | $64.14 | $5.3B | -0.27% | +154.84% | $58.1K | -0.86% | — | Stalk |
| Jan 29, 2024 | Sell | APLS | Karen Lewis | Chief People Officer | 1,250 | $65.12 | $5.3B | -0.27% | +154.84% | $81.4K | -1.32% | 10b5-1 | Stalk |
| Jan 29, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 1,250 | $65.22 | $5.3B | -0.27% | +154.84% | $81.5K | -1.07% | 10b5-1 | Stalk |
| Jan 29, 2024 | Sell | APLS | Cedric Francois | Chief Executive Officer | 2,843 | $64.14 | $5.3B | -0.27% | +154.84% | $182.3K | -0.89% | — | Stalk |
| Jan 23, 2024 | Sell | APLS | Karen Lewis | Chief People Officer | 4,286 | $63.69 | $5.3B | -0.27% | +154.84% | $273.0K | -8.25% | 10b5-1 | Stalk |
| Jan 23, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 7,378 | $63.69 | $5.3B | -0.27% | +154.84% | $469.9K | -11.21% | 10b5-1 | Stalk |
| Jan 22, 2024 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 1,061 | $65.00 | $5.3B | -0.27% | +154.84% | $69.0K | -2.64% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,384 | $65.00 | $5.3B | -0.27% | +154.84% | $90.0K | -2.07% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 1,607 | $65.00 | $5.3B | -0.27% | +154.84% | $104.4K | -2.38% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Karen Lewis | Chief People Officer | 1,738 | $65.00 | $5.3B | -0.27% | +154.84% | $113.0K | -3.24% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 2,593 | $65.00 | $5.3B | -0.27% | +154.84% | $168.5K | -3.66% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 3,413 | $65.00 | $5.3B | -0.27% | +154.84% | $221.8K | -3.49% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 3,551 | $65.00 | $5.3B | -0.27% | +154.84% | $230.8K | -3.58% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 3,913 | $65.00 | $5.3B | -0.27% | +154.84% | $254.3K | -0.35% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | David O. Watson | General Counsel | 4,184 | $65.00 | $5.3B | -0.27% | +154.84% | $271.9K | -3.83% | — | Stalk |
| Jan 22, 2024 | Sell | APLS | Cedric Francois | Chief Executive Officer | 13,431 | $65.00 | $5.3B | -0.27% | +154.84% | $873.0K | -4.02% | — | Stalk |
| Jan 17, 2024 | Sell | APLS | Karen Lewis | Chief People Officer | 3,276 | $65.58 | $5.3B | -0.27% | +154.84% | $214.8K | -5.75% | 10b5-1 | Stalk |
| Jan 17, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 5,207 | $65.58 | $5.3B | -0.27% | +154.84% | $341.5K | -7.17% | 10b5-1 | Stalk |
| Jan 16, 2024 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 438 | $66.81 | $5.3B | -0.27% | +154.84% | $29.3K | -0.43% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 864 | $66.81 | $5.3B | -0.27% | +154.84% | $57.7K | -1.63% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 1,631 | $66.81 | $5.3B | -0.27% | +154.84% | $109.0K | -1.75% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Karen Lewis | Chief People Officer | 1,632 | $66.81 | $5.3B | -0.27% | +154.84% | $109.0K | -1.96% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Pascal Deschatelets | Chief Scientific Officer | 1,632 | $66.81 | $5.3B | -0.27% | +154.84% | $109.0K | -0.14% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 1,857 | $66.81 | $5.3B | -0.27% | +154.84% | $124.1K | -1.84% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 2,235 | $66.81 | $5.3B | -0.27% | +154.84% | $149.3K | -1.64% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 2,235 | $66.81 | $5.3B | -0.27% | +154.84% | $149.3K | -1.66% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | David O. Watson | General Counsel | 4,240 | $66.81 | $5.3B | -0.27% | +154.84% | $283.3K | -2.86% | — | Stalk |
| Jan 16, 2024 | Sell | APLS | Cedric Francois | Chief Executive Officer | 7,851 | $66.81 | $5.3B | -0.27% | +154.84% | $524.5K | -1.76% | — | Stalk |
| Jan 4, 2024 | Sell | APLS | Caroline Baumal | Chief Medical Officer | 2,751 | $60.05 | $5.3B | -0.27% | +154.84% | $165.2K | -7.71% | — | Stalk |
| Dec 26, 2023 | Sell | APLS | Jeffrey Eisele | Chief Development Officer | 303 | $59.70 | $5.3B | -0.27% | +154.84% | $18.1K | -0.28% | 10b5-1 | Stalk |
| Dec 19, 2023 | Buy | APLS | David O. Watson | General Counsel | 11,810 | $28.19 | $5.3B | -0.27% | +154.84% | $333.0K | +1.45% | — | Stalk |
| Dec 1, 2023 | Sell | APLS | Lukas Scheibler | Chief Research Officer | 20,000 | $36.92 | $5.3B | -0.27% | +154.84% | $738.5K | +0.00% | 10b5-1 | Stalk |
| Dec 1, 2023 | Sell | APLS | Adam J. Townsend | Chief Commercial Officer | 220,000 | $37.95 | $5.3B | -0.27% | +154.84% | $8.3M | +0.00% | 10b5-1 | Stalk |
| Nov 30, 2023 | Sell | APLS | Timothy Eugene Sullivan | Chief Financial Officer | 28,316 | $32.38 | $5.3B | -0.27% | +154.84% | $916.9K | +0.00% | 10b5-1 | Stalk |
| Nov 21, 2023 | Sell | APLS | Cedric Francois | Chief Executive Officer | 5,000 | $48.80 | $5.3B | -0.27% | +154.84% | $244.0K | -1.82% | — | Stalk |
| Nov 14, 2023 | Buy | APLS | Pascal Deschatelets | Chief Scientific Officer | 45,000 | $3.76 | $5.3B | -0.27% | +154.84% | $169.2K | +3.61% | — | Stalk |
| Nov 8, 2023 | Buy | APLS | Pascal Deschatelets | Chief Scientific Officer | 29,494 | $20.82 | $5.3B | -0.27% | +154.84% | $613.9K | +0.26% | 10b5-1 | Stalk |
| Oct 23, 2023 | Sell | APLS | Mark Jeffrey Delong | Chief Business & Strat Officer | 131 | $46.04 | $5.3B | -0.27% | +154.84% | $6.0K | -0.25% | — | Stalk |
| Oct 23, 2023 | Sell | APLS | James George Chopas | VP/Chief Accounting Officer | 132 | $46.04 | $5.3B | -0.27% | +154.84% | $6.1K | -0.40% | — | Stalk |
| Oct 9, 2023 | Buy | APLS | Pascal Deschatelets | Chief Scientific Officer | 30,500 | $17.51 | $5.3B | -0.27% | +154.84% | $534.0K | +0.30% | 10b5-1 | Stalk |
| Sep 19, 2023 | Sell | APLS | Cedric Francois | Chief Executive Officer | 300,000 | $48.30 | $5.3B | -0.27% | +154.84% | $14.5M | +0.00% | — | Stalk |
| Sep 18, 2023 | Sell | APLS | Nur Nicholson | Chief Technical Officer | 30,069 | $39.58 | $5.3B | -0.27% | +154.84% | $1.2M | -3.36% | — | Stalk |